Phibro Animal Health Corporation (PAHC) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 6 recommend buying, 3 recommend holding, and 4 recommend selling.
The analyst consensus price target for PAHC is $49.00, representing a -17.0% downside from the current price of $59.02. Price targets range from a low of $49.00 to a high of $49.00.
